worried said...
but the doubling time is relatively short.
There is no validation for a "doubling time" for uPSA tests. I don't think anyone has found an actionable use for uPSA while a man is taking ADT.
worried said...
The only reason it is not high enough for auxin is that the FDA says it should be 0.2 ...RO says C11 will show mets at his PSA level.
The
reason the FDA says it should be over 0.2 is because it does not typically find metastases at a PSA that low. Yet it is among the best PET scans - much better, in fact, than C-11 Choline. C-11 Choline isn't at all reliable when the PSA is below 2.0. You can see the various PET scans and their PSA ranges in the table at this link:
/pcnrv.blogspot.com/2016/12/pet-scans-for-prostate-cancer.htmlAt his current PSA, with his mets all shrunken by hormone therapy, you would be wasting your time and money by getting
any PET scan. If he is given a vacation from hormone therapy they might show up, but if CRPC is starting, that could be risky, and for little potential benefit.
The odds that the cancer is still only in his pelvic LNs is very low now that it is 5 years after it was first discovered there. With ePLND, there is risk of lymphocele and lymphedema. On the other hand, there may be benefit to starting second line hormonal therapy sooner (Zytiga or Xtandi).